Although FRAX does not have specific inputs for cancer and cancer treatments, may be an accurate predictor of fracture risk in patients with cancer, especially when BMD is included.
Adherence to the guidelines for osteoporosis screening in this study was poor, although the study did not demonstrate this leading to more adverse events for total joint surgery vs the national average.
Among nearly 40,000 patients hospitalized for a fragility fracture, less than one-third filled a prescription for antiosteoporosis medication during the year following hospital discharge.